Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Study this chart. Except for the blow off distribution (guess who) 2006 tops

" those communications must be reviewed and approved by TPL before they are made public. "

Is that a courtesy to TPL or part of the MA or any other contract??

It is a contractual obligation per the Master Agreement, as most are aware of and have noted for some time.

.

.

.

Be well

Share
New Message
Please login to post a reply